Find therapies in clinical trials near you – page 118

Study of MK-1088 and Pembrolizumab for Patients with Advanced Solid Tumors

Study of MK-1088 and Pembrolizumab for Patients with Advanced Solid Tumors

Study on Dasatinib and Quercetin for Patients with Osteoporosis or Osteopenia

Study on Dasatinib and Quercetin for Patients with Osteoporosis or Osteopenia

Study on the Use of Hyperpolarized Xenon (129Xe) and Gadobutrol for Imaging in Patients with Progressive Fibrosing Interstitial Lung Diseases

Study on the Use of Hyperpolarized Xenon (129Xe) and Gadobutrol for Imaging in Patients with Progressive Fibrosing Interstitial Lung Diseases

Long-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Multiple Myeloma, or Acute Leukemia

Long-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Multiple Myeloma, or Acute Leukemia

Study on the Effectiveness and Safety of Oral Azacitidine for Patients with Low or Intermediate-Risk Myelodysplastic Syndrome

Study of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy

Study of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy

Study on the Safety of Ibuprofen for Patients Experiencing Pain After Hip and Knee Replacement Surgery

Study on the Safety of Ibuprofen for Patients Experiencing Pain After Hip and Knee Replacement Surgery

Study on Oral Roflumilast for Treating Chronic Hand Eczema in Adults

Study on Oral Roflumilast for Treating Chronic Hand Eczema in Adults

Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

Study on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients

Study Comparing Dupilumab and Mepolizumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Danish Patients

Study Comparing Dupilumab and Mepolizumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Danish Patients

Study of Tislelizumab, Gemcitabine, and Cisplatin for Patients with Relapsed or Refractory Hodgkin Lymphoma in Metabolic Complete Remission

Study of Tislelizumab, Gemcitabine, and Cisplatin for Patients with Relapsed or Refractory Hodgkin Lymphoma in Metabolic Complete Remission

Study of Flu Vaccine and Pembrolizumab for Patients with Early Colorectal Cancer

Study of Flu Vaccine and Pembrolizumab for Patients with Early Colorectal Cancer